期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Molecular Mechanism Underlying Plant Response to Cold Stress
1
作者 yiwei cao Delight Hwarari +2 位作者 Yasmina Radani Yuanlin Guan Liming Yang 《Phyton-International Journal of Experimental Botany》 SCIE 2023年第9期2665-2682,共18页
Low temperature stress is one of the most important factors limiting plant growth and geographical distribution.In order to adapt to low temperature,plants have evolved strategies to acquire cold tolerance,known as,co... Low temperature stress is one of the most important factors limiting plant growth and geographical distribution.In order to adapt to low temperature,plants have evolved strategies to acquire cold tolerance,known as,cold acclimation.Current molecular and genomic studies have reported that annual herbaceous and perennial woody plants share similar cold acclimation mechanisms.However,woody perennials also require extra resilience to survive cold winters.Thus,trees have acquired complex dynamic processes to control the development of dormancy and cold resistance,ensuring successful tolerance during the coldest winter season.In this review,we systemically described how woody plants perceive and transduce cold stress signals through a series of physiological changes such as calcium signaling,membrane lipid,and antioxidant changes altering downstream gene expression and epigenetic modification,ultimately bud dormancy.We extended the discussion and reviewed the processes endogenous phytohormones play in regulating the cold stress.We believe that this review will aid in the comprehension of underlying mechanisms in plant acclimation to cold stress. 展开更多
关键词 Calcium signaling cold stress C-repeat binding factor(CBF) DORMANCY plants
下载PDF
630nm激光联合血卟啉衍生物治疗晚期支气管肺癌的近期临床疗效分析
2
作者 李林宇 崔世超 +2 位作者 杨晓晖 曹艺巍 林存智 《中华临床医师杂志(电子版)》 CAS 2024年第2期133-138,共6页
目的探讨630 nm激光联合血卟啉衍生物治疗晚期支气管肺癌的近期临床疗效及安全性。方法选择青岛大学附属医院2019年3月至2023年9月经病理确诊的43例晚期支气管肺癌患者,行支气管肺癌介入治疗后,联合630 nm激光和血卟啉衍生物及化疗、免... 目的探讨630 nm激光联合血卟啉衍生物治疗晚期支气管肺癌的近期临床疗效及安全性。方法选择青岛大学附属医院2019年3月至2023年9月经病理确诊的43例晚期支气管肺癌患者,行支气管肺癌介入治疗后,联合630 nm激光和血卟啉衍生物及化疗、免疫治疗。随访患者基本临床特征及治疗后的不良反应,治疗后1个月复查胸部CT及支气管镜检查。结果胸部CT显示治疗后气管或支气管内肿瘤体积较术前明显缩小,改善通气。支气管镜检查显示,治疗后肿瘤体积减小,甚至消失。治疗1个月后按时复查胸部CT及支气管镜检查的患者为31例(72.09%),31例患者的总有效率70.97%。43例患者均未出现严重并发症,但3例患者出现常见并发症。结论630 nm激光联合血卟啉衍生物治疗晚期支气管肺癌近期临床疗效明显,能改善气道狭窄,缓解呼吸困难、咳嗽等症状,安全性好,值得在临床推广应用。 展开更多
关键词 630nm激光 血叶啉衍生物 肺癌 光动力疗法 近期疗效
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部